Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Biotech Fund Ltd Efficacy currently holds 8,342,046 shares of REPROS THERAPEUTICS INC. (RPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Biotech Fund Ltd Efficacy has been a net buyer of RPRX stock. They have purchased $1.4M and sold $62.5K worth of shares.
Biotech Fund Ltd Efficacy's most recent insider trade was on Feb 16, 2011, when they sold 57,600 shares at $0.97 per share.
Biotech Fund Ltd Efficacy serves as Executive at REPROS THERAPEUTICS INC. (RPRX). They have executed 6 insider transactions totaling $1.5M over their tenure at the company.
Biotech Fund Ltd Efficacy holds the position of Executive at REPROS THERAPEUTICS INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Biotech Fund Ltd Efficacy has shown a buying trading pattern, with $1.4M in total purchases and $62.5K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Biotech Fund Ltd Efficacy was on Dec 6, 2007, when they purchased $477.6K worth of RPRX shares. This transaction involved 60,000 shares at $7.96 per share.
Biotech Fund Ltd Efficacy currently owns 8,342,046 shares of REPROS THERAPEUTICS INC. (RPRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Biotech Fund Ltd Efficacy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Biotech Fund Ltd Efficacy has 6 Form 4 filings on record as an insider at REPROS THERAPEUTICS INC..
Set alerts for Biotech Fund Ltd Efficacy and 40,000+ other insiders.